OraSure Technologies Acquires UrSure

May 29, 2020

OraSure Technologies, Inc. has agreed to acquire UrSure, Inc., a Boston-based developer of tests that measure adherence to HIV medications including PrEP, for $3 million upfront plus up to $28 million in contingent consideration. The acquisition expands OraSure's point-of-care and infectious disease diagnostic offerings and strengthens its position in the HIV market by adding adherence-monitoring products and related laboratory capabilities.

Buyers
OraSure Technologies, Inc.
Targets
UrSure, Inc.
Industry
Medical Devices
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.